News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Alessandro Gronchi: A recap of the most important studies of Sarcoma from 2023 and 2024
Alessandro Gronchi and Winan van Houdt
Dec 12, 2024, 15:54

Alessandro Gronchi: A recap of the most important studies of Sarcoma from 2023 and 2024

Alessandro Gronchi, Director of the Department of Oncological Surgery at the Fondazione IRCCS National Cancer Institute of Milan, shared a post on LinkedIn:

“A recap of the most important studies from 2023 and 2024 can be found here!

Congratulations to all the investigators for their great work!

The sarcoma research community is united and continues to achieve significant results despite the challenges posed by the rarity and heterogeneity of this disease.

Connective Tissue Oncology Society, Society of Surgical Oncology, European Society of Surgical Oncology (ESSO), Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, David Thomas, B. Ashleigh Guadagnolo, MD, MPH, FASTRO, Fabio Tirotta, Bernd Kasper, Patricia Pautier, Yvonne Mowery, Winan van Houdt and more!”

Sarcoma: Last Year’s Practice Changing Papers

Authors: Winan J van Houdt and Alessandro Gronchi

Alessandro Gronchi: A recap of the most important studies of Sarcoma from 2023 and 2024

Alessandro Gronchi B. Ashleigh Guadagnolo Bernd Kasper cancer Connective Tissue Oncology Society David Thomas ESSO european society of surgical oncology Fabio Tirotta FASTRO fight against cancer Fondazione IRCCS Global fight against cancer MD Milan MPH National Cancer Institute OncoDaily Oncological Surgery Oncology Patricia Pautier recap Society of Surgical Oncology Winan van Houdt Yvonne Mowery
Special Coverage
Career
Apr 1, 2025, 16:02
Jay Bhattacharya begins his tenure as the 18th NIH Director - National Institutes of Health
Positive
Apr 1, 2025, 15:45
Mark Lanasa: Positive CHMP opinion for BeOne Medicines' first-line immunotherapy in ES-SCLC
Blog
Apr 1, 2025, 15:09
Hagop Kantarjian: Success, optimism, and challenges on the therapeutic horizon of acute myeloid leukemia
Blog
Apr 1, 2025, 15:04
Call for Papers: AI in Immune-Related Adverse Events (irAEs) - AI in Precision Oncology
Career
Apr 1, 2025, 14:57
Sharon Burk completes PhD with groundbreaking research - Sbarro Health Research Organization
Blog
Apr 1, 2025, 14:35
Douglas Flora: The messy truth behind healthcare's coming AI adoption
Blog
Apr 1, 2025, 14:31
Zainab Shinkafi-Bagudu: Processed meats and fried snacks may increase the risk of colorectal cancer
Societies
Apr 1, 2025, 14:08
Myeloma Paper of the Day, April 1st, suggested by Robert Orlowski
Blog
Apr 1, 2025, 12:54
CTOS Communications Committee's survey to understand your engagement with social media
Science
Apr 1, 2025, 12:48
Yan Leyfman: Dual-Targeted CAR-T Therapy Shows 100% Response in MCL
Blog
Apr 1, 2025, 12:43
By 2040, the global burden of colorectal cancer is expected to rise by 63% - Digestive Cancers Europe
Blog
Apr 1, 2025, 12:34
Asya Agulnik: Breakthrough approaches needed for pediatric cancer treatment in conflict-affected regions